Your email was sent successfully. Check your inbox.

An error occurred while sending the email. Please try again.

Proceed reservation?

Export
  • 1
    Keywords: ANGIOGENESIS ; CANCER ; SURVIVAL ; tumor ; Germany ; THERAPY ; DENSITY ; DIAGNOSIS ; imaging ; liver ; NEW-YORK ; SAMPLE ; SAMPLES ; TISSUE ; TUMORS ; NUCLEAR-MEDICINE ; PATIENT ; BIOMARKERS ; TISSUES ; MAGNETIC-RESONANCE ; magnetic resonance imaging ; BREAST ; immunohistochemistry ; REGION ; REGIONS ; MUSCLE ; PARAMETERS ; NORMAL TISSUE ; SERIES ; CONTRAST-ENHANCED MRI ; nuclear medicine ; ASBESTOS ; mesothelioma ; MALIGNANT MESOTHELIOMA ; LUNG-CARCINOMA ; HETEROGENEITY ; radiology ; RE ; THERAPIES ; monitoring ; dynamic contrast enhanced MRI ; biomarker ; analysis ; methods ; SUBTYPES ; NUCLEAR ; USA ; correlation ; spleen ; Aorta ; microvascular density ; MEDICINE ; quantitative ; PHARMACOKINETIC ANALYSIS ; DCE-MRI ; neoplasm ; CD-34 ; IMAGING BIOMARKER
    Abstract: Rationale and Objectives. Malignant mesothelioma (MM) of the pleura is an aggressive and often fatal neoplasm. Because MM frequently demonstrates marked angiogenesis, it may be responsive to antiangiogenic therapy, but effective methods for selecting and monitoring of patients are further needed. We employed dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) and quantitative immunohistochemistry (IHC) to characterize the microvascularity of MM using both a physiologic and ultrastructural method. Materials and Methods. Nineteen patients diagnosed with MM were enrolled and DCE-MRI was performed before antiangiogenic treatment. For each patient, tumor regions were characterized by their DCE-MRI-derived pharmacokinetic parameters (Amp, k(ep), k(el)), which were also compared to those of normal tissue (aorta, liver, spleen, and muscle). In addition, quantitative ITIC of representative samples was performed with CD-34 staining to compare the calculated microvessel density (MVD) results with DCE-MRI results. Results. MM demonstrated markedly abnormal pharmacokinetic properties compared with normal tissues. Among the parameters tested, Amp was significantly different in MM (P :5.001) compared to normal organs. Despite the observation that the MVD of mesotheliomas in this series was high compared to other tumors, DCE-MRI pharmacokinetic parameters had a moderately positive correlation with MVD (r = 0.5). Conclusions. DCE-MRI and IHC can be used in patients with MM to visualize tumor microvascularity and to characterize tumor heterogeneity. DCE-MRI and IHC results positively correlated, though moderately, but these two methods present as essential tumor biomarkers. This multimodal characterization may be useful in selecting possible tumor subtypes that would benefit from antiangiogenic therapy
    Type of Publication: Journal article published
    PubMed ID: 18423312
    Signatur Availability
    BibTip Others were also interested in ...
Close ⊗
This website uses cookies and the analysis tool Matomo. More information can be found here...